獸醫產業的驅蟲藥：市場現況及未來發展前景（2007年）

本報告已在2011年08月03日停止出版。

目錄

Abstract

“Globally, this segment had a value of approximately $5.1 billion in 2006, making it the single most valuable sector within the animal health market… and therefore probably the most competitive.”

This report analyzes the structure, recent development and growth prospects of the world market for antiparasitics and profiles several key national markets that generate two-thirds of global sales in the sector between them.

Key coverage

• Assess the most significant parasites affecting companion and food producing animals, and the impact they have on their host.
• Examine the methods used to treat or control the parasites with all major product categories discussed in detail including mode of action and spectrum of activity.
• Analyse company profiles for both originator companies with major interests in the sector as well as generic manufacturers to help you identify competitors.
• Identify the size and structure of the world market, it' s recent developments and future growth prospects to help you plan your future strategy.

Market data

The ultimate guide to the animal health industry and its major players is updated and improved for 2007. With 26 company profiles included to further enhance your competitor intelligence

In-depth company profiles are given for the top 12 animal health companies and a further 14 second tier companies.

Key Findings

The continuous growth of the whole segment in recent years has mostly been due to the new products commercialised in the companion animal ectoparasiticides segment.

However, sales in other parts of the market have been affected by growing generic penetration.

The development of vaccines against parasites is still a subject of high interest in both the academic and commercial sectors. However outside the coccidiosis sector these have generated fairly modest revenues to date.

The major players in the sector are working on the development of novel antiparasitics, and some new products are expected to reach the market in the next 5 years.

Chapters

• Major Livestock and Companion Animal Parasites
• Antiparasitic Products
• The Market for Antiparasitic Products
• Company Profiles - for originator companies and generic manufacturers

Who should read this report?

Companies that are involved in the development, manufacture and sale of animal health products either as originator companies or generic manufacturers.

Table of Contents

CHAPTER 1 - PARASITES IN DOMESTIC ANIMALS

• 1.1 Introduction
  • 1.1.1 Life cycles of parasites
  • 1.1.2 Pathogenic potential
• 1.2 Dog parasites
  • 1.2.1 Endoparasites
    • Gastrointestinal roundworms
    • Lungworms
    • Tapeworms
    • Heartworm
    • Protozoa
    • Treatment and control
  • 1.2.2 Ectoparasites
    • Fleas
    • Ticks
    • Mites
    • Treatment and control
• 1.3 Cat parasites
  • 1.3.1 Endoparasites
    • Gastrointestinal roundworms
    • Protozoa
  • 1.3.2 Ectoparasites
    • Fleas
    • Mites
• 1.4 Horse parasites
  • 1.4.1 Endoparasites
    • Treatment and control
  • 1.4.2 Ectoparasites
    • Treatment and control
• 1.5 Cattle parasites
  • 1.5.1 Endoparasites
    • Gastrointestinal nematodes
    • Tapeworms
    • Lungworms
    • Liver fluke
    • Protozoa
    • Treatment and control of cattle endoparasites
  • 1.5.2 Ectoparasites
    • Flies
    • Lice
    • Mites
    • Ticks
    • Treatment and control
• 1.6 Sheep parasites
  • 1.6.1 Endoparasites
    • Gastrointestinal nematodes
    • Tapeworms
    • Lungworms
    • Liver flukes
    • Protozoa
    • Treatment and control
  • 1.6.2 Ectoparasites
    • Flies
    • Mites
    • Lice
    • Ticks
    • Treatment and control
• 1.7 Pig parasites
  • 1.7.1 Endoparasites
    • Gastrointestinal nematodes
    • Protozoa
    • Treatment and control
  • 1.7.2 Ectoparasites
    • Treatment and control

CHAPTER 2 - ANTIPARASITIC PRODUCTS

• 2.1 Endoparasiticides
  • 2.1.1 Imidazothiazoles
  • 2.1.2 Benzimidazoles
  • 2.1.3 Tetrahydropyrimidines
  • 2.1.4 Macrocyclic lactones
  • 2.1.5 Cyclic depsipeptides
  • 2.1.6 Other endoparasiticides
• 2.2 Endectocides
  • 2.2.1 Avermectins
    • Ivermectin
    • Abamectin
    • Eprinomectin
    • Doramectin
    • Selamectin
    • Emamectin
  • 2.2.2 Milbemycins
    • Moxidectin
    • Milbemycin oxime
  • 2.2.3 Quasi-endectocides
• 2.3 Ectoparasiticides
  • 2.3.1 Pyrethrins and synthetic pyrethroids
  • 2.3.2 Organophosphates
  • 2.3.3 Carbamates
  • 2.3.4 Macrocyclic lactones
  • 2.3.5 Formamidines
  • 2.3.6 Pyrazoles
  • 2.3.7 Neonicotinoids
  • 2.3.8 Insect growth regulators
    • Juvenile hormone analogues
    • Chitin synthesis inhibitors
    • Other insect growth regulators
  • 2.3.9 Spinosyns
  • 2.3.10 Semicarbazones
• 2.4 Combination products
• 2.5 Parasite vaccines
  • Parasitic bronchitis vaccine
  • Cattle tick vaccine
  • Giardiasis vaccine
  • Toxoplasmosis vaccine
  • Neosporosis vaccine
  • Babesia vaccine
• 2.6 Antiparasitic research
  • 2.6.1 Endoparasiticide and endectocide research
  • 2.6.2 Ectoparasiticide research
  • 2.6.3 Parasite vaccine research
  • 2.6.4 Alternative approaches to parasite control

CHAPTER 3 - THE MARKET FOR ANTIPARASITIC PRODUCTS

• 3.1 The world market for animal health products
  • 3.1.1 Structure of the world market by product category
• 3.2 The world market for antiparasitic products
  • 3.2.1 Antiparasitic product sectors
  • 3.2.2 Company involvement
  • 3.2.3 Leading country markets
  • 3.2.4 Market prospects
• 3.3 National market profiles
  • 3.3.1 Australia
    • 3.3.1.1 Market size and recent growth
    • 3.3.1.2 Market structure
    • 3.3.1.3 Structure and development of the Australian antiparasitics market
      • Large animal antiparasitics
      • Small animal antiparasitics
    • 3.3.1.4 Antiparasitic market prospects
      • Market forecast
  • 3.3.2 Brazil
    • 3.3.2.1 Market size and recent growth
    • 3.3.2.2 Market structure
    • 3.3.2.3 Structure and development of the Brazilian antiparasitics market
      • Anthelmintics
      • Ectoparasiticides
      • Endectocides
    • 3.3.2.4 Antiparasitic market prospects
      • Market forecast
  • 3.3.3 France
    • 3.3.3.1 Market size and recent growth
    • 3.3.3.2 Market structure
    • 3.3.3.3 Structure and development of the French antiparasitics market
      • Anthelmintics
      • Insecticides/ectoparasiticides
      • Endectocides
    • 3.3.3.4 Antiparasitic market prospects
      • Market forecast
  • 3.3.4 Japan
    • 3.3.4.1 Market size and recent growth
    • 3.3.4.2 Market structure
    • 3.3.4.3 Structure and development of the Japanese antiparasitics market
      • Anthelmintics
      • Endectocides
      • Ectoparasiticides
    • 3.3.4.4 Antiparasitic market prospects
    • 3.3.4.5 Market forecast
  • 3.3.5 UK
    • 3.3.5.1 Market size, structure and recent growth
    • 3.3.5.2 Structure and development of the UK antiparasitics market
      • Anthelmintics
      • Ectoparasiticides
      • Endectocides
    • 3.3.5.3 Antiparasitic growth prospects
      • Market forecast
  • 3.3.6 USA
    • 3.3.6.1 Market size and recent growth
    • 3.3.6.2 Market structure
    • 3.3.6.3 Size and structure of the US antiparasitics market
      • Pet flea/tick treatments
      • Other ectoparasitic segments
      • Heartworm preventatives
      • Other pet wormers
      • Cattle wormers
      • Equine anthelmintics
    • 3.3.6.4 Antiparasitic market prospects
      • Market forecast
  • 3.3.7 Other significant markets
    • 3.3.7.1 Germany
    • 3.3.7.2 Italy
    • 3.3.7.3 New Zealand
    • 3.3.7.4 Spain

CHAPTER 4 - COMPANY PROFILES

• 4.1 Leading companies
  • 4.1.1 Bayer
    • 4.1.1.1 Company background
    • 4.1.1.2 Major antiparasitic products
      • Imidacloprid
      • Other ectoparasiticides
      • Anthelmintics and endectocides
    • 4.1.1.3 Antiparasitic research
  • 4.1.2 Fort Dodge
    • 4.1.2.1 Company background
    • 4.1.2.2 Antiparasitics business
    • 4.1.2.3 Major antiparasitic products
      • Moxidectin
      • Metaflumizone
      • Other antiparasitics
  • 4.1.2.4 Antiparasitic research
  • 4.1.3 Intervet
    • 4.1.3.1 Company background
    • 4.1.3.2 Antiparasitics business
    • 4.1.3.3 Major antiparasitic products
      • Fenbendazole
      • Other anthelmintics and endectocides
      • Ectoparasiticides
      • Vaccines
    • 4.1.3.4 Antiparasitic research
  • 4.1.4 Merial
    • 4.1.4.1 Company background
    • 4.1.4.2 Antiparasitics business
    • 4.1.4.3 Major antiparasitic products
      • Fipronil
      • Avermectins
      • Others
    • 4.1.4.4 Antiparasitic research
  • 4.1.5 Novartis
    • 4.1.5.1 Company background
    • 4.1.5.2 Antiparasitics business
    • 4.1.5.3 Major antiparasitic products
      • Milbemycin oxime
      • Lufenuron
      • Other companion animal antiparasitics
      • Livestock products
      • Premise and environmental parasite controls
    • 4.1.5.4 Antiparasitic research
  • 4.1.6 Pfizer
    • 4.1.6.1 Company background
    • 4.1.6.2 Antiparasitics business
    • 4.1.6.3 Major antiparasitic products
      • Avermectins
      • Others
  • 4.1.6.4 Antiparasitic research
  • 4.1.7 Schering-Plough
    • 4.1.7.1 Company background
    • 4.1.7.2 Antiparasitics business
    • 4.1.7.3 Major antiparasitic products
      • Ectoparasiticides
      • Anthelmintics
      • Endectocides
    • 4.1.7.4 Antiparasitic research
  • 4.1.8 Virbac
    • 4.1.8.1 Company background
    • 4.1.8.2 Antiparasitics business
    • 4.1.8.3 Antiparasitic products
      • Endectocides
      • Others
    • 4.1.8.4 Antiparasitic research
• 4.2 Major generic companies
  • 4.2.1 Ancare
    • 4.2.1.1 Company background
    • 4.2.1.2 Strategy
    • 4.2.1.3 Antiparasitic product range
  • 4.2.2 Central Garden & Pet
    • 4.2.2.1 Company background
    • 4.2.2.2 Wellmark
    • 4.2.2.3 Farnam
      • Veterinary Products Laboratories
  • 4.2.3 IVX Animal Health
    • 4.2.3.1 Company background
      • Phoenix Scientific
      • DVM Pharmaceuticals
  • 4.2.4 Norbrook
    • 4.2.4.1 Company background
    • 4.2.4.2 Strategy
    • 4.2.4.3 Antiparasitic product range

REFERENCES

LIST OF TABLES

• Table 1.1: Transmission of roundworms in dogs
• Table 1.2: Major internal parasites of dogs
• Table 1.3: Major external parasites of dogs
• Table 1.4: Major internal parasites of cats
• Table 1.5: Major internal parasites of horses
• Table 1.6: Major external parasites of horses
• Table 1.7: Major internal parasites of cattle
• Table 1.8: Major external parasites of cattle
• Table 1.9: Major internal parasites of sheep
• Table 1.10: Major external parasites of sheep
• Table 1.11: Major internal parasites of pigs
• Table 2.1: Antiparasitic molecules commercialized since 1990
• Table 2.2: Leading benzimidazole products and proprietary trade names
• Table 2.3: Anthelmintic spectrum of efficacy of selected endoparasiticides
• Table 2.4: Novel flea control products and their indications
• Table 3.1: World animal health product sales, 2000-2006
• Table 3.2: Structure of the world market by product category, 2006
• Table 3.3: Leading national markets for antiparasitics, 2006
• Table 3.4: Antiparasitic market growth forecasts, 2006-2011
• Table 3.5: Development of the Australian market, 2005-2006
• Table 3.6: Structure of the Australian market, 2006
• Table 3.7: Antiparasitic sales by product/species segment, 2006
• Table 3.8: Antiparasitic sales growth and market share, 2000-2006
• Table 3.9: Development of the Brazilian market, 2002-2006
• Table 3.10: Development of product categories, 2005-2006
• Table 3.11: Structure of the Brazilian market, 2006
• Table 3.12: Antiparasitics segments in Brazil, 2002-2006
• Table 3.13: Development of the French market, 2000-2006
• Table 3.14: Structure of the French market, 2006
• Table 3.15: Antiparasitic sales and market share, 2001 and 2006
• Table 3.16: Antiparasitic sales by product segment, 2001 and 2006
• Table 3.17: Development of the Japanese market, 2000-2006
• Table 3.18: Structure of the Japanese market, 2006
• Table 3.19: Antiparasitic sales and market share, 2001 and 2006
• Table 3.20: Structure of the Japanese antiparasitics market, 2006
• Table 3.21: Development of the UK market, 2005-06
• Table 3.22: UK antiparasitic sales by product segment, 2006
• Table 3.23: Development of antiparasitic segments, 2005-06
• Table 3.24: Development of the US market, 2000-2006
• Table 3.25: Structure of the US market, 2006
• Table 3.26: Segments of the US antiparasitics market, 2006
• Table 3.27: Second tier antiparasitic markets, 2006
• Table 3.28: Development of the German market 2002 - 2006
• Table 3.29: German antiparasitic sales growth and market share
• Table 3.30: Development of the Italian market 2002 - 2006
• Table 3.31: Development of the Spanish market 2002 - 2006
• Table 4.1: Leading players in the antiparasitics market, 2006
• Table 4.2: Imidacloprid revenues, 2000-2006
• Table 4.3: Imidacloprid product launches
• Table 4.4: Merial antiparasitics sales, 2006
• Table 4.5: Frontline sales development, 2000-2004
• Table 4.6: Leading formulations in the Merial ivermectin range
• Table 4.7: Merial's avermectin sales, 2000-2006
• Table 4.8: Novartis' companion animal parasite control range

相關商品

矚目市場調查報告書

Animal Pharm：動物健康及營養

Animal Pharm

價格 : US $ 2260

動物用醫藥相關市場調查報告書

動物健康市場
Veterinary Health Markets
價格 : US $ 3400
出版日期 : 2012年01月

動物生物科技：技術・市場・企業
Animal Biotechnology - Technologies, Markets and Companies
價格 : US $ 3000
出版日期 : 2012年01月

美國的寵物用醫藥品市場：做為消費者產品的處方藥與OTC藥（第2版）
Pet Medications in the U.S.: Prescription and Over-the-Counter Remedies as Consumer Products, 2nd Edition
價格 : US $ 3300
出版日期 : 2011年10月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!